talinolol has been researched along with acetaminophen in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Bernsdorf, A; Giessmann, T; Hartmann, V; Modess, C; Mrazek, C; Nagel, S; Siegmund, W; Wegner, D; Weitschies, W; Zschiesche, M | 1 |
Hopfgartner, G; Tonoli, D; Varesio, E | 1 |
1 trial(s) available for talinolol and acetaminophen
Article | Year |
---|---|
The talinolol double-peak phenomenon is likely caused by presystemic processing after uptake from gut lumen.
Topics: Acetaminophen; Administration, Oral; Administration, Rectal; Adult; Area Under Curve; Biological Availability; Capsules; Delayed-Action Preparations; Diterpenes; Drug Administration Schedule; Gelatin; Half-Life; Humans; Intestinal Absorption; Male; Postprandial Period; Propanolamines; Retinyl Esters; Time Factors; Vitamin A | 2005 |
4 other study(ies) available for talinolol and acetaminophen
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
High-resolution mass spectrometry for integrated qualitative and quantitative analysis of pharmaceuticals in biological matrices.
Topics: Acetaminophen; Bosentan; Chromatography, High Pressure Liquid; Humans; Mass Spectrometry; Microsomes, Liver; Propanolamines; Sulfonamides | 2012 |